Stock INDIES INDIES PHARMA JAMAICA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Indies Pharma Jamaica Limited

Equities

INDIES

JME201800161

Pharmaceuticals

End-of-day quote JAMAICA STOCK EXCHANGE
Other stock markets
 03:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
2.65 JMD 0.00% Intraday chart for Indies Pharma Jamaica Limited +1.53% -14.24%
17/06 Indies Pharma Jamaica Limited Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 CI
14/03 Indies Pharma Jamaica Limited Reports Earnings Results for the First Quarter Ended January 31, 2024 CI

Valuation

Fiscal Period: Oktober 2019 2020 2021 2022 2023
Capitalization 1 4,131 3,598 4,531 4,184 4,184
Enterprise Value (EV) 1 4,024 4,172 5,177 4,765 4,830
P/E ratio 31.5 x 17.4 x 25 x 19 x 19.6 x
Yield - 5.19% 3.24% 3.6% 3.61%
Capitalization / Revenue 5.66 x 4.7 x 5.35 x 4.46 x 3.96 x
EV / Revenue 5.52 x 5.45 x 6.11 x 5.08 x 4.58 x
EV / EBITDA 27.1 x 18.3 x 21 x 15.8 x 16.7 x
EV / FCF -952 x -14.6 x -84.3 x 42.8 x 65.7 x
FCF Yield -0.11% -6.84% -1.19% 2.34% 1.52%
Price to Book 5.94 x 4.57 x 6.03 x 3.62 x 3.43 x
Nbr of stocks (in thousands) 13,32,537 13,32,537 13,32,537 13,32,537 13,32,537
Reference price 2 3.100 2.700 3.400 3.140 3.140
Announcement Date 12/02/20 28/01/21 13/04/22 10/02/23 31/01/24
1JMD in Million2JMD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Oktober 2018 2019 2020 2021 2022 2023
Net sales 1 636.2 729.5 765.9 846.8 937.3 1,055
EBITDA 1 171 148.4 227.8 247 301 289.1
EBIT 1 157 136.1 216.5 230.9 281.7 270.2
Operating Margin 24.68% 18.66% 28.27% 27.26% 30.06% 25.6%
Earnings before Tax (EBT) 1 138 127.8 208.7 181.3 220.8 217.6
Net income 1 119.7 131 206.6 181.3 220.8 213.1
Net margin 18.82% 17.95% 26.98% 21.41% 23.56% 20.19%
EPS 2 0.0898 0.0983 0.1551 0.1361 0.1657 0.1599
Free Cash Flow 1 67.77 -4.226 -285.5 -61.42 111.4 73.53
FCF margin 10.65% -0.58% -37.28% -7.25% 11.89% 6.97%
FCF Conversion (EBITDA) 39.63% - - - 37.03% 25.43%
FCF Conversion (Net income) 56.62% - - - 50.47% 34.51%
Dividend per Share 2 0.0800 - 0.1400 0.1100 0.1130 0.1133
Announcement Date 10/01/19 12/02/20 28/01/21 13/04/22 10/02/23 31/01/24
1JMD in Million2JMD
Estimates

Balance Sheet Analysis

Fiscal Period: Oktober 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 575 647 581 645
Net Cash position 1 97.5 107 - - - -
Leverage (Debt/EBITDA) - - 2.522 x 2.619 x 1.93 x 2.232 x
Free Cash Flow 1 67.8 -4.23 -286 -61.4 111 73.5
ROE (net income / shareholders' equity) 24.2% 19.2% 27.9% 24.7% 19.7% 17.9%
ROA (Net income/ Total Assets) 11.7% 10.5% 10.6% 8.58% 8.62% 7.88%
Assets 1 1,023 1,249 1,949 2,115 2,561 2,705
Book Value Per Share 2 0.5000 0.5200 0.5900 0.5600 0.8700 0.9100
Cash Flow per Share 2 0.0800 0.0900 0.2400 0.1400 0.1800 0.1900
Capex 1 1.66 60.3 431 35.3 26.4 14
Capex / Sales 0.26% 8.26% 56.3% 4.17% 2.81% 1.33%
Announcement Date 10/01/19 12/02/20 28/01/21 13/04/22 10/02/23 31/01/24
1JMD in Million2JMD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
INDIES PHARMA JAMAICA LIMITED Stock Indies Pharma Jamaica Limited
-14.24% 2.27Cr
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-0.86% 2.43TCr
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+15.06% 874.36Cr
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+1.47% 821.21Cr
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-31.14% 687.43Cr
H. LUNDBECK A/S Stock H. Lundbeck A/S
+18.74% 528.62Cr
GALENICA AG Stock Galenica AG
+1.03% 412.62Cr
EBOS GROUP LIMITED Stock EBOS Group Limited
-9.24% 379.17Cr
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
-8.91% 334.49Cr
MEDIPAL HOLDINGS CORPORATION Stock MediPal Holdings Corporation
+7.11% 319.77Cr
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. INDIES Stock
  4. Financials Indies Pharma Jamaica Limited